Table 3.
Cox univariate analysis for 180-day mortality
| Variable | n | 180-day mortality | ||
|---|---|---|---|---|
| HR | 95 % CI | p | ||
| Age, years | 135 | 1.04 | 1.01–1.07 | 0.005 |
| SAPS II, point | 130 | 1.06 | 1.05–1.08 | <0.0001 |
| Sex | ||||
| Female | 51 | ref. | ||
| Male | 84 | 1.42 | 0.70–2.89 | 0.331 |
| Chronic disease | ||||
| No | 49 | ref. | ||
| Yes | 86 | 1.81 | 0.85–3.84 | 0.124 |
| Pentraxin-3 | ||||
| Low ≤52.4 ng/mL | ref. | |||
| High >52.4 ng/mL | 2.60 | 1.28–5.29 | 0.008 | |
| Procalcitonin | ||||
| Low ≤7.73 μg/L | ref. | |||
| High >7.73 μg/L | 2.22 | 1.11–4.44 | 0.024 | |
| C-reactive protein | ||||
| Low ≤222 mg/L | ref. | |||
| High >222 mg/L | 0.44 | 0.22–0.89 | 0.021 | |
Markers are divided by high versus low concentrations according to median values
CI Confidence interval, HR Hazard ratio, ref. Referent, SAPS II Simplified Acute Physiology Score II